Gsk Buildcon Private Limited - Company Profile

It is a real estate private limited company based in Delhi, Delhi, India, established in 2011.
2011 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Gsk Buildcon Private Limited

Gsk Buildcon Private Limited, a struck off private limited company, was established on 17 February 2011 in Delhi, Delhi, India. Engaging in real estate leasing within the real estate sector, it holds CIN: U70200DL2011PTC214255. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Gourish Kumar Jagatramka (Director), Satyam Jagatramka (Director). Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at X/50,1St Floor Pratap Gali,Gandhi Nagar, Delhi, Delhi, 110031.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U70200DL2011PTC214255

  • Registration Number

    214255

  • Incorporation Date

    17 February 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 17 Days
  • Last Filing with ROC 31 Mar 2017
Company report

Gsk Buildcon Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gsk Buildcon Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gsk Buildcon Private Limited?
Current Directors
Name Designation Appointment Date Status
Gourish Kumar Jagatramka Director 17 Feb 2011 Current
Satyam Jagatramka Director 17 Feb 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gsk Buildcon.

Gsk Buildcon Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Gsk Buildcon revenue growth over time
Gsk Buildcon profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gsk Buildcon?

In 2017, Gsk Buildcon had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gsk Buildcon?

Unlock and access historical data on people associated with Gsk Buildcon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gsk Buildcon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsk Buildcon's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gsk Buildcon
Recent Activity within the Organization
  • Annual General Meeting

    The activity Gsk Buildcon Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Gsk Buildcon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi. was documented.

  • Director Appointment

    The activity Gourish Kumar Jagatramka was appointed as a Director was appointed as a Director on 17 Feb 2011 & has been associated with this company since 15 years 17 days . was completed.

  • Director Appointment

    The activity Satyam Jagatramka was appointed as a Director was appointed as a Director on 17 Feb 2011 & has been associated with this company since 15 years 17 days . was completed.

  • Company Incorporation

    The activity Gsk Buildcon Private Limited was registered on 17 Feb 2011 with Roc Delhi & aged 15 years 17 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gsk Buildcon Private Limited?

The CIN of Gsk Buildcon Private Limited is U70200DL2011PTC214255.

Where is Gsk Buildcon Private Limited headquartered?

Gsk Buildcon Private Limited is headquartered at X/50,1St Floor Pratap Gali,Gandhi Nagar, Delhi, Delhi, 110031.

When was Gsk Buildcon Private Limited incorporated?

Gsk Buildcon Private Limited was incorporated on 17 February 2011.

Who are the current directors of Gsk Buildcon Private Limited?

The current directors of Gsk Buildcon Private Limited are

What is the primary industry of Gsk Buildcon Private Limited?

The primary industry of Gsk Buildcon Private Limited is Real Estate.

Is Gsk Buildcon Private Limited a listed company?

Gsk Buildcon Private Limited is unlisted.

What is the capital structure of Gsk Buildcon Private Limited?

The authorized capital of Gsk Buildcon Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available